Peroxisome Proliferator-Activated Receptors in HBV-Related Infection by Laurent Dubuquoy, Alexandre Louvet, Antoine Hollebecque, Philippe Mathurin, Sébastien Dharancy

Get full text

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic... by Jean-Marie Michot, Zsofia Balogh, Jennifer R. Brown, Vincent Ribrag, Antoine Hollebecque, Rastislav Bahleda, Cyril Quivoron, Samy Ammari, Jean-Yves Scoazec, Karim A. Benhadji, Christophe Massard

Get full text

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types by Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard

Get full text

Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma by Dimitrios Papakonstantinou, Haiding Wang, Mohamed-Amine Bani, Kevin Mulder, Garett Dunsmore, Alice Boilève, Gérôme Jules-Clément, Leonardo Panunzi, Leslie Robert de Sousa, Carlos de la Calle Fabregat, Marc Deloger, Nicolas Signolle, Grégoire Gessain, Sergey I Nikolaev, Michel Ducreux, Antoine Hollebecque, Florent Ginhoux, Camille Blériot

Get full text

Correction to “New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe” [The Lancet Regional Health – Europe, volume 50, Ma... by Lorenza Rimassa, Angela Lamarca, Grainne M. O'Kane, Julien Edeline, Mairéad G. McNamara, Arndt Vogel, Matteo Fassan, Alejandro Forner, Timothy Kendall, Jorge Adeva, Andrea Casadei-Gardini, Lorenzo Fornaro, Antoine Hollebecque, Maeve A. Lowery, Teresa Macarulla, David Malka, Elene Mariamidze, Monica Niger, Anu Ustav, John Bridgewater, Rocio I.R. Macias, Chiara Braconi

Get full text